drugset / Press release
Material Information - The Company Announces Submission of Marketing Authorization Application of Ropeginterferon alfa-2b (P1101) for ET in China
2025-06-30 · PharmaEssentia · original pharmaessentia.com ↗
Download Material Information - The Company Announces Submission of Marketing Authorization Application of Ropeginterferon alfa-2b (P1101) for ET in China Previous Next
The release as fetched from its publisher. pharmaessentia.com ↗